Company Filing History:
Years Active: 2006
Title: **Innovator Spotlight: Sara Alonso Villanueva**
Introduction
Sara Alonso Villanueva is a notable inventor based in Bilbao, Spain. She has made significant contributions to the field of vaccine development, particularly through her innovative patent in recombinant viral genome technology. Her work is crucial in advancing the efficacy of vaccines across various animal species.
Latest Patents
Sara Alonso Villanueva holds a patent for "Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines." This invention involves vectors comprising a recombinant defective viral genome that expresses at least one antigen, which is essential for inducing systemic and secretory immune responses or an antibody that offers protection against infectious agents. The unique aspect of her patent lies in its design, which includes viral replicase recognition signals positioned at both the 3' and 5' ends, along with specific internal deletions. This defective genome is designed to rely on a helper virus for replication and encapsidation, making it a potential game-changer in vaccine formulation. Her vectors are particularly relevant for creating mono- and polyvalent vaccines against infectious agents affecting different animal species, particularly pigs, dogs, and cats.
Career Highlights
Sara has carved a niche for herself in the realm of biotechnological innovations through her work at Cyanamid Ibérica, S.A. Her efforts are directed towards enhancing vaccine development, which plays a vital role in animal health. With her unique research focus, she has successfully integrated cutting-edge science with practical applications in veterinary medicine.
Collaborations
Throughout her career, Sara has collaborated with esteemed colleagues such as Luis Enjuanes Sanchez and Juan Plana Duran. These partnerships have allowed for the sharing of expertise and resources, significantly enhancing the scope and impact of her research within the scientific community.
Conclusion
Sara Alonso Villanueva's innovative contributions to vaccine development position her as a leading figure in biotechnology. Her patented work not only marks a milestone in scientific advancement but also underscores the importance of collaboration in driving innovation. As she continues her journey in this dynamic field, her efforts will undoubtedly have lasting effects on animal health and disease prevention.